BLFS PE Ratio & Valuation, Is BLFS Overvalued

Historical Valuation

BioLife Solutions Inc (BLFS) is now in the Overvalued zone, suggesting that its current forward PS ratio of 10.86 is considered Overvalued compared with the five-year average of -247.56. The fair price of BioLife Solutions Inc (BLFS) is between 9.58 to 19.20 according to relative valuation method. Compared to the current price of 19.90 USD , BioLife Solutions Inc By Overvalued By 3.64%.

Relative Value

Fair Zone

9.58-19.20

Current Price：19.90

3.64%

Overvalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is BioLife Solutions Inc (BLFS) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

BioLife Solutions Inc (BLFS) has a current Price-to-Book (P/B) ratio of 3.24. Compared to its 3-year average P/B ratio of 2.87, the current P/B ratio is approximately 13.02% higher. Relative to its 5-year average P/B ratio of 2.98, the current P/B ratio is about 8.61% higher. BioLife Solutions Inc (BLFS) has a Forward Free Cash Flow (FCF) yield of approximately 0.87%. Compared to its 3-year average FCF yield of -1.16%, the current FCF yield is approximately -174.96% lower. Relative to its 5-year average FCF yield of -1.55%, the current FCF yield is about -156.44% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for BLFS competitors is 4.73, providing a benchmark for relative valuation. BioLife Solutions Inc Corp (BLFS.O) exhibits a P/S ratio of 10.86, which is 129.68% above the industry average. Given its robust revenue growth of 24.34%, this premium appears sustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of BLFS increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of BLFS in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is BLFS currently overvalued or undervalued?

What is BioLife Solutions Inc (BLFS) fair value?

BLFS's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of BioLife Solutions Inc (BLFS) is between 9.58 to 19.20 according to relative valuation method.

How does BLFS's valuation metrics compare to the industry average?

The average P/S ratio for BLFS's competitors is 4.73, providing a benchmark for relative valuation. BioLife Solutions Inc Corp (BLFS) exhibits a P/S ratio of 10.86, which is 129.68% above the industry average. Given its robust revenue growth of 24.34%, this premium appears sustainable.

What is the current P/B ratio for BioLife Solutions Inc (BLFS) as of Mar 11 2026?

As of Mar 11 2026, BioLife Solutions Inc (BLFS) has a P/B ratio of 3.24. This indicates that the market values BLFS at 3.24 times its book value.

What is the current FCF Yield for BioLife Solutions Inc (BLFS) as of Mar 11 2026?

As of Mar 11 2026, BioLife Solutions Inc (BLFS) has a FCF Yield of 0.87%. This means that for every dollar of BioLife Solutions Inc's market capitalization, the company generates 0.87 cents in free cash flow.

What is the current Forward P/E ratio for BioLife Solutions Inc (BLFS) as of Mar 11 2026?

As of Mar 11 2026, BioLife Solutions Inc (BLFS) has a Forward P/E ratio of 411.90. This means the market is willing to pay $411.90 for every dollar of BioLife Solutions Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for BioLife Solutions Inc (BLFS) as of Mar 11 2026?

As of Mar 11 2026, BioLife Solutions Inc (BLFS) has a Forward P/S ratio of 10.86. This means the market is valuing BLFS at $10.86 for every dollar of expected revenue over the next 12 months.

BLFS Valuation